Pro-Dex reported nice Q1 sales of $19.9 million, which is up 14.6% YoY. Their largest customer contr

Ascendiant Capital analyst Edward Woo maintains Pro-Dex (NASDAQ:PDEX) with a Buy and raises the p

Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $1.20 per share which beat the analyst consensu

IRVINE, CA / ACCESS Newswire / April 30, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financ

Shares of Pro-Dex, Inc. (NASDAQ: PDEX - Get Free Report) passed above its two hundred day moving ave

PRO-DEX, INC. (NasdaqCM:PDEX) today announced that on February 9, 2026 it completed its acquisition

IRVINE, CA / ACCESS Newswire / February 12, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced tha

IRVINE, CA / ACCESS Newswire / January 29, 2026 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced fina

Pro-Dex (NASDAQ: PDEX - Get Free Report) and STAAR Surgical (NASDAQ: STAA - Get Free Report) are bot

Pro-Dex manufactures powered surgical instruments for orthopedic, CMF, and thoracic procedures. This

D.A. Davidson and CO. boosted its stake in Pro-Dex, Inc. (NASDAQ: PDEX) by 152.3% in the undefined q

Pro-Dex Inc. is a specialized surgical device manufacturer with strong growth, efficient capital all

Cardinal Health (NYSE: CAH - Get Free Report) and Pro-Dex (NASDAQ: PDEX - Get Free Report) are both

Pro-Dex (NASDAQ: PDEX - Get Free Report) and Spotlight Innovation (OTCMKTS:STLT - Get Free Report) a

IRVINE, CA / ACCESS Newswire / December 19, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced tha

Spotlight Innovation (OTCMKTS:STLT - Get Free Report) and Pro-Dex (NASDAQ: PDEX - Get Free Report) a

Lifevantage (NASDAQ: LFVN - Get Free Report) and Pro-Dex (NASDAQ: PDEX - Get Free Report) are both s

Pro-Dex, Inc. (PDEX) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensu

Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $1.40 per share which beat the analyst consensu

IRVINE, CA / ACCESS Newswire / October 30, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced fina

D.A. Davidson and CO. purchased a new stake in Pro-Dex, Inc. (NASDAQ: PDEX) in the undefined quarter

PRO-DEX, INC. (NasdaqCM:PDEX) is issuing this press release in an effort to help avoid any confusion

IRVINE, CA / ACCESS Newswire / October 16, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) is issuing this pres

Pro-Dex, Inc. (PDEX) came out with quarterly earnings of $0.36 per share, missing the Zacks Consensu

IRVINE, CA / ACCESS Newswire / September 4, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced fin

Ascendiant Capital analyst Edward Woo maintains Pro-Dex (NASDAQ:PDEX) with a Buy and raises the p

Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.98 per share which beat the analyst consensu

Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.61 per share which beat the analyst consensu

Ascendiant Capital analyst Edward Woo maintains Pro-Dex (NASDAQ:PDEX) with a Buy and raises the p

Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.75 per share which beat the analyst consensu

Ascendiant Capital analyst Edward Woo maintains Pro-Dex (NASDAQ:PDEX) with a Buy and raises the p

Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.46 per share which beat the analyst consensu

Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.19 per share which missed the analyst consen

Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.14 per share which missed the analyst consen

Pro-Dex (NASDAQ:PDEX) reported quarterly losses of $(0.17) per share which missed the analyst consen

Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.42 per share which beat the analyst consensu